Literature DB >> 11315067

Design of validation studies for estimating the odds ratio of exposure-disease relationships when exposure is misclassified.

C A Holcroft1, D Spiegelman.   

Abstract

We compared several validation study designs for estimating the odds ratio of disease with misclassified exposure. We assumed that the outcome and misclassified binary covariate are available and that the error-free binary covariate is measured in a subsample, the validation sample. We considered designs in which the total size of the validation sample is fixed and the probability of selection into the validation sample may depend on outcome and misclassified covariate values. Design comparisons were conducted for rare and common disease scenarios, where the optimal design is the one that minimizes the variance of the maximum likelihood estimator of the true log odds ratio relating the outcome to the exposure of interest. Misclassification rates were assumed to be independent of the outcome. We used a sensitivity analysis to assess the effect of misspecifying the misclassification rates. Under the scenarios considered, our results suggested that a balanced design, which allocates equal numbers of validation subjects into each of the four outcome/mismeasured covariate categories, is preferable for its simplicity and good performance. A user-friendly Fortran program is available from the second author, which calculates the optimal sampling fractions for all designs considered and the efficiencies of these designs relative to the optimal hybrid design for any scenario of interest.

Mesh:

Substances:

Year:  1999        PMID: 11315067     DOI: 10.1111/j.0006-341x.1999.01193.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  17 in total

1.  Gene-environment interactions in cancer epidemiology: a National Cancer Institute Think Tank report.

Authors:  Carolyn M Hutter; Leah E Mechanic; Nilanjan Chatterjee; Peter Kraft; Elizabeth M Gillanders
Journal:  Genet Epidemiol       Date:  2013-10-05       Impact factor: 2.135

2.  Structured measurement error in nutritional epidemiology: applications in the Pregnancy, Infection, and Nutrition (PIN) Study.

Authors:  Brent A Johnson; Amy H Herring; Joseph G Ibrahim; Anna Maria Siega-Riz
Journal:  J Am Stat Assoc       Date:  2007       Impact factor: 5.033

3.  The impact of gene-environment dependence and misclassification in genetic association studies incorporating gene-environment interactions.

Authors:  Sara Lindström; Yu-Chun Yen; Donna Spiegelman; Peter Kraft
Journal:  Hum Hered       Date:  2009-06-11       Impact factor: 0.444

4.  Novel two-phase sampling designs for studying binary outcomes.

Authors:  Le Wang; Matthew L Williams; Yong Chen; Jinbo Chen
Journal:  Biometrics       Date:  2019-11-14       Impact factor: 2.571

5.  Hierarchical Semi-Bayes Methods for Misclassification in Perinatal Epidemiology.

Authors:  Richard F MacLehose; Lisa M Bodnar; Craig S Meyer; Haitao Chu; Timothy L Lash
Journal:  Epidemiology       Date:  2018-03       Impact factor: 4.822

6.  Validity of birth certificate-derived maternal weight data.

Authors:  Lisa M Bodnar; Barbara Abrams; Marnie Bertolet; Alison D Gernand; Sara M Parisi; Katherine P Himes; Timothy L Lash
Journal:  Paediatr Perinat Epidemiol       Date:  2014-03-27       Impact factor: 3.980

7.  Validity of birth certificate-derived maternal weight data in twin pregnancies.

Authors:  Lisa M Bodnar; Barbara Abrams; Lara Siminerio; Timothy L Lash
Journal:  Matern Child Nutr       Date:  2014-12-17       Impact factor: 3.092

8.  Comparison of bias analysis strategies applied to a large data set.

Authors:  Timothy L Lash; Barbara Abrams; Lisa M Bodnar
Journal:  Epidemiology       Date:  2014-07       Impact factor: 4.822

Review 9.  Use of pathway information in molecular epidemiology.

Authors:  Duncan C Thomas; David V Conti; James Baurley; Frederik Nijhout; Michael Reed; Cornelia M Ulrich
Journal:  Hum Genomics       Date:  2009-10       Impact factor: 4.639

10.  Power/sample size calculations for assessing correlates of risk in clinical efficacy trials.

Authors:  Peter B Gilbert; Holly E Janes; Yunda Huang
Journal:  Stat Med       Date:  2016-03-31       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.